JP Morgan Maintains Underweight on Archer-Daniels-Midland, Lowers Price Target to $75
JP Morgan analyst Thomas Palmer maintains Archer-Daniels-Midland (NYSE:ADM) with a Underweight and lowers the price target from $77 to $75.
Stocks · News reference
Toast To Rally More Than 15%? Here Are 10 Top Analyst Forecasts For Wednesday
Wall Street analysts changed outlook on top names. UBS cut Fidelity National Information target, JP Morgan downgraded Ball, Needham raised Hinge Health.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Jim Cramer Doesn’t Like This Health Care Stock, Sees No Reason To Buy Rambus
Cramer dislikes Rambus and MiniMed, calls GigaCloud highly speculative, sees Babcock & Wilcox as a small bet, and favors ADM and Deere.
CJ CheilJedang, ADM Agree To Create Joint Venture Over Source Of Feed-Grade Amino Acids For U.S. Livestock Sector
SupplySide Global Brings Together Ingredient and Supplement Ecosystem for Discovery, Education and Business Acceleration
SupplySide Global returns to Las Vegas October 26-30, 2026, featuring 1,600+ exhibiting companies, 135 hours of educational programming, and expanded networking opportunities. The event brings together ingredient suppliers, manufacturers, brands, and service providers from the supplement, food, and beverage industries for discovery and business acceleration.
Shares of semiconductor and chip companies are trading lower as rising inflation concerns and elevated energy prices fuel expectations for further Fed rate hikes. Elevated borrowing costs could pressure semiconductor manufacturing and AI infrastructure investments while straining customer budgets. The Philadelphia Semiconductor Index (SOX) has declined for seven consecutive trading sessions, matching its longest losing streak since the 2008 financial crisis.
Arm vs. Credo Technology Group: Which Semiconductor Stock Is a Better Buy in 2026?
The article compares two semiconductor companies: Arm, which licenses chip architecture used in billions of devices globally with strong profitability and low risk, and Credo Technology Group, which provides high-speed interconnects for AI data centers with explosive 205% revenue growth but higher customer concentration risk. The author recommends Credo for its superior growth trajectory despite Arm's defensible business model.